Harnessing Optimism and Perseverance in the Face of Long COVID-Español
Part of paid clinical trials in New York, New York.
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Study ID
- NCT07216040
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Post-Acute COVID-19 Syndrome
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- HOPE-LC~Espanol — BEHAVIORAL12-week online group therapy program grounded in principles of Acceptance and Commitment Therapy and tailored specifically to living with Long COVID as a chronic condition. HOPE-LC provides community and hope; fostering resilience, adjustment, and critical coping strategies in the face of this debilitating chronic condition.
Study Details
The Harnessing Optimism and Perseverance in the Face of Long COVID (HOPE-LC) program, created by Drs. Eric Watson and Amelia Hicks, is a group therapy model designed to foster resilience, adjustment, and coping skills for those living with chronic Long COVID. HOPE-LC\~Español provides a culturally and linguistically adapted version for Spanish-speaking individuals in Queens, developed with input from Spanish-speaking clinicians, Long COVID experts, and people with lived experience. Partnering with H+H/Elmhurst and H+H/Queens, the project aims to recruit 25 participants and evaluate program feasibility and preliminary efficacy.
Key Dates
- Start date
- May 31, 2026
- Status verified
- Apr 2026
- Primary completion
- Aug 31, 2026
- Completion
- Aug 31, 2026
Study Design
- Enrollment
- 25 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Patients Living with Chronic Long-COVIDSpanish-speaking patients in the HOPE-LC program.
Primary Outcome Measure
Recruitment rate [ Time Frame: Throughout the study period, 12 weeks ]
Central Contacts
- Eric Watson, PhD212-241-2221
- Amelia Hicks, PhD212-241-2221
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Brain Injury Research Center | New York | New York | 10029 | Eric Watson (PRINCIPAL_INVESTIGATOR) |
Find similar trials in New York, NY
Related Studies
- Long-Covid-19 Alleviation Through Learning Mindfulness StudyRecruiting · Columbia University · New York, New York
- Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation ResearchRecruiting · Brain Inflammation Collaborative · Delafield, Wisconsin
- Cardiovascular Autonomic and Immune Mechanism of Post COVID-19 Tachycardia SyndromeRecruiting · Vanderbilt University Medical Center · Nashville, Tennessee
- Care for Veterans Post-COVID-19Recruiting · VA Office of Research and Development · East Orange, New Jersey